Experimental analysis demonstrates inefficiencies in nuclease prime editors during large-fragment DNA deletions, highlighting the need for optimized precision genome editing platforms.
Among 241,074 known pathogenic or likely pathogenic human genetic variants, ~27.7% were deletions or replacements (i.e., insertions following deletions) 1 . Many abnormal deletions and replacements involved relatively large DNA fragments, including ~953 variants with deletions exceeding 1 kb (Supplementary Fig. S1a ), posing a major challenge for genome editing. The prime editing (PE) system represented a significant breakthrough for diverse genome editing, while it was limited for deleting larger DNA fragments 2 , 3 . The recently reported nuclease-based prime editor (PEn) combined with paired pegRNAs provided a novel prime editing tool for large-fragment deletions and simultaneous insertions 4 , 5 . However, the current platforms based on PEn still exhibited overall suboptimal efficiencies and produced unwanted edits, significantly hindering the applicability of this versatile tool.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: